Coukos G - Search Results

1

Sensitive identification of neoantigens and cognate TCRs in human solid tumors.

Arnaud M, Chiffelle J, Genolet R, Navarro Rodrigo B, Perez MAS, Huber F, Magnin M, Nguyen-Ngoc T, Guillaume P, Baumgaertner P, Chong C, Stevenson BJ, Gfeller D, Irving M, Speiser DE, Schmidt J, Zoete V, Kandalaft LE, Bassani-Sternberg M, Bobisse S, Coukos G, Harari A. Arnaud M, et al. Among authors: coukos g. Nat Biotechnol. 2022 May;40(5):656-660. doi: 10.1038/s41587-021-01072-6. Epub 2021 Nov 15. Nat Biotechnol. 2022. PMID: 34782741 Free PMC article.

2

Endothelin B receptor, a new target in cancer immune therapy.

Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Clin Cancer Res. 2009 Jul 15;15(14):4521-8. doi: 10.1158/1078-0432.CCR-08-0543. Epub 2009 Jun 30. Clin Cancer Res. 2009. PMID: 19567593 Free PMC article. Review.

3

The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.

Kandalaft LE, Singh N, Liao JB, Facciabene A, Berek JS, Powell DJ Jr, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Gynecol Oncol. 2010 Feb;116(2):222-33. doi: 10.1016/j.ygyno.2009.11.001. Epub 2009 Dec 2. Gynecol Oncol. 2010. PMID: 19959212 Free PMC article. Review.

4

Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin.

Kandalaft LE, Motz GT, Busch J, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Curr Top Microbiol Immunol. 2011;344:129-48. doi: 10.1007/82_2010_95. Curr Top Microbiol Immunol. 2011. PMID: 20680802 Review.

5

Immunotherapy for ovarian cancer: what's next?

Kandalaft LE, Powell DJ Jr, Singh N, Coukos G. Kandalaft LE, et al. Among authors: coukos g. J Clin Oncol. 2011 Mar 1;29(7):925-33. doi: 10.1200/JCO.2009.27.2369. Epub 2010 Nov 15. J Clin Oncol. 2011. PMID: 21079136 Free PMC article. Review.

6

Tumor immune surveillance and ovarian cancer: lessons on immune mediated tumor rejection or tolerance.

Kandalaft LE, Motz GT, Duraiswamy J, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Cancer Metastasis Rev. 2011 Mar;30(1):141-51. doi: 10.1007/s10555-011-9289-9. Cancer Metastasis Rev. 2011. PMID: 21298574 Review.

7

Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines.

Chiang CL, Kandalaft LE, Coukos G. Chiang CL, et al. Among authors: coukos g. Int Rev Immunol. 2011 Apr-Jun;30(2-3):150-82. doi: 10.3109/08830185.2011.572210. Int Rev Immunol. 2011. PMID: 21557641 Review.

8

Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responses.

Chiang CL, Hagemann AR, Leskowitz R, Mick R, Garrabrant T, Czerniecki BJ, Kandalaft LE, Powell DJ Jr, Coukos G. Chiang CL, et al. Among authors: coukos g. PLoS One. 2011;6(12):e28732. doi: 10.1371/journal.pone.0028732. Epub 2011 Dec 14. PLoS One. 2011. PMID: 22194898 Free PMC article.

9

A phase I clinical trial of adoptive transfer of folate receptor-alpha redirected autologous T cells for recurrent ovarian cancer.

Kandalaft LE, Powell DJ Jr, Coukos G. Kandalaft LE, et al. Among authors: coukos g. J Transl Med. 2012 Aug 3;10:157. doi: 10.1186/1479-5876-10-157. J Transl Med. 2012. PMID: 22863016 Free PMC article. Clinical Trial.

10

Conference scene: Immune signatures in the tumor and beyond.

Kandalaft LE, Kalos M, Melief CJ, Speiser DE, Coukos G. Kandalaft LE, et al. Among authors: coukos g. Immunotherapy. 2012 Aug;4(8):761-72. doi: 10.2217/imt.12.70. Immunotherapy. 2012. PMID: 22947003 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

395 results

Search Page